Mosanna Therapeutics Announces a Seed Financing Round to Advance Development of MOS118 to Treat Metabolic Obstructive Sleep Apnea
/PRNewswire/ -- Mosanna Therapeutics AG, a Swiss Biotech company today announced that it has secured seed financing led by Forty51 Ventures to pursue the...